Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections

BACKGROUND: Optimal timing for rifampicin combination therapy in patients with staphylococcal vascular graft/endograft infection (S-VGEI) is unknown. Experts recommend adding rifampicin after lowering bacterial load by surgery and wound closure. OBJECTIVES: To assess predictors of rifampicin resista...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JAC Antimicrob Resist
Auteurs principaux: Leung, Yau Kei Stefan, Ledergerber, Bruno, Eberhard, Nadia, Mestres, Carlos A, Rancic, Zoran, Zimmermann, Alexander, Zbinden, Reinhard, Brugger, Silvio D, Zinkernagel, Annelies S, Hasse, Barbara
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8209986/
https://ncbi.nlm.nih.gov/pubmed/34223108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jacamr/dlab041
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires